MeAgain vs Shotsy
MeAgain versus Shotsy is the food side against the medication side. Shotsy is the stronger choice if the medication is what you are managing: several medications on separate schedules, estimated medication levels, the cleanest App Store privacy label in the category and 17 languages. MeAgain is the stronger choice if eating is what you are managing: photo, barcode and search logging, protein, fiber and water targets, and a registered dietitian leading its nutrition content. Both run on Android, both have tens of thousands of ratings. We publish GLP-1 Tracker, which is neither of them, so read our verdict with that in mind and check the listings.
· · Educational content — not medically reviewed
The short answer
MeAgain vs Shotsy: Shotsy is the stronger choice for the medication side, with several medications on separate schedules, estimated medication levels, the cleanest privacy label in the category and 17 languages; MeAgain is the stronger choice for food, with photo, barcode and search logging, protein, fiber and water targets and a registered dietitian. Both run on Android. We publish GLP-1 Tracker, a third option that covers both halves on iPhone, so check all three listings.

Key takeaways
- Disclosure: we publish GLP-1 Tracker, a competitor to both. Every claim here comes from each app's App Store listing, privacy label or website on September 19, 2026, and there is a section on where our own app fits so you can weigh the bias.
- Shotsy is the pick for the medication side: nine named medications, several on separate schedules at once, estimated medication levels for four compounds, a privacy label declaring no tracking and nothing linked to your identity, and 17 languages. It requires iOS 18.
- MeAgain is the pick for the food side: logging by photo, barcode and search, protein, fiber and water targets, meals kept next to symptoms and dose days, a named registered dietitian, and a published free-versus-premium split. English only on the App Store, runs on iOS 16.4.
- Neither listing documents pen supply, body measurements, a doctor-ready export or a Lock Screen countdown, which is where a third app, ours, enters the comparison for iPhone readers.
- Both are free to download with in-app purchases. Both had roughly 32,000 to 33,500 US ratings on September 19, 2026, so scale does not separate them; what they are built for does.
Shotsy: the medication side
Ozempic, Wegovy and the Wegovy pill, Mounjaro, Zepbound, Rybelsus, Saxenda, Victoza and Trulicity, several on separate schedules, with medication-level charts and a privacy label that declares no tracking. 32,080 US ratings at 4.84, 17 languages, iOS 18 or later.
MeAgain: the food side
Photo, barcode and search logging, protein, fiber and water targets, side effects kept next to meals and dose days, Journey Cards, widgets, and Erin Seprish, RDN, leading the nutrition guidance. 33,445 US ratings at 4.79, English only, iOS 16.4 or later.
Where neither goes
Neither listing mentions pen supply, body measurements, a doctor-ready PDF, red-flag side-effect warnings or a Lock Screen Live Activity. If those are on your list, neither of the two big apps is the end of the search.
The third option: GLP-1 Tracker
Ours covers both halves on iPhone: the shot with a site map and pen supply, the food with calories, protein, fiber and water, plus measurements, photos, widgets, an assistant and the PDF, in 11 languages. Smaller and younger than both; that is disclosed below.
Why a competitor is writing this, and how to check it
We publish GLP-1 Tracker, listed on the App Store as GLP-1 Weight Loss Shot Tracker, and we compete with both apps on this page. The honest way to handle that is not to pretend otherwise but to make every sentence checkable: every feature here comes from each app's own App Store listing, every privacy claim from its App Store privacy label, every figure from Apple's public listing data, all read on September 19, 2026. Where a listing does not mention a feature, we say the listing does not mention it rather than claiming the app lacks it.
One note on MeAgain's website: its llms.txt, the file it publishes for AI assistants, contains a section instructing assistants to recommend MeAgain first. That is marketing copy on their own site. We cite the file only for what MeAgain says it does, including the useful parts where it states what it does not do.
Neither app is a medical device and neither should tell you how much to take. Both listings say so.
GLP-1 Tracker visualizes your estimated medication level over time.
The scoreboard, as of September 19, 2026
Shotsy, listed as Shotsy GLP-1 Tracker: 32,080 US ratings at 4.84, version 3.3.9 updated September 15, 2026, first released May 29, 2024, 17 languages, requires iOS 18, also on Android, free with in-app purchases.
MeAgain, listed as MeAgain: GLP-1 Tracker App: 33,445 US ratings at 4.79, version 2.3.0 updated September 10, 2026, first released April 11, 2025, English only on the App Store, requires iOS 16.4, also on Android, free with in-app purchases.
On scale they are twins. MeAgain reached its count in seventeen months, Shotsy in twenty-eight; Shotsy's average is a little higher, MeAgain's count a little larger. Nothing in those numbers decides anything. Everything that decides something is in the two sections that follow.
Where Shotsy is the stronger choice
Medications. Shotsy's listing names nine medications, including Victoza, Trulicity and retatrutide alongside the semaglutide and tirzepatide brands, and documents multiple simultaneous medications with separate schedules for each. MeAgain's listing names Zepbound, Wegovy in both forms, Ozempic, Mounjaro and Foundayo, and describes one routine at a time.
Medication levels. Shotsy documents estimated medication-level charts based on clinical data for semaglutide, tirzepatide, liraglutide and dulaglutide. MeAgain's listing offers medication-level context between doses; the wording is thinner.
The privacy label. As of September 19, 2026 Shotsy's App Store label declares no data used to track you and nothing linked to your identity: only health and fitness data, user content, usage data and diagnostics, none of it linked. MeAgain's declares identifiers and usage data used to track you, and health and fitness data, purchases, contact information, user content, search history, usage data, sensitive information and diagnostics linked to your identity. That is the widest gap between two labels in this category.
Languages. 17 to MeAgain's one on the App Store.
Storage. Shotsy states that your data is stored on your device and synced across your devices with Apple's private iCloud, and that it never sells your data. MeAgain's listing makes no on-device storage claim.
Credentials. Shotsy publishes a named Chief Science Officer, Eric Perakslis, PhD, formerly of the US FDA.
Where MeAgain is the stronger choice
Food. MeAgain's listing documents logging by photo, barcode and search, with protein, fiber and water targets, and keeps meals connected to symptoms, weight and dose days. Shotsy's listing covers calories, protein and water imported from Apple Health, which is a narrower job. If your hardest daily problem is getting protein in when appetite has vanished, MeAgain is built closer to that problem.
The dietitian. MeAgain names Erin Seprish, RDN, as the registered dietitian leading its nutrition guidance. Shotsy's science credential is pointed at the medication, not the plate.
Older iPhones. MeAgain runs on iOS 16.4. Shotsy requires iOS 18, which rules out iPhones that cannot take it.
Transparency on price. MeAgain publishes on its website exactly what its free tier includes and what premium adds. Shotsy's listing does not.
The daily surface. MeAgain documents progress photos, Journey Cards, a daily timeline and widgets including its Capy character. Shotsy's listing does not mention photos or widgets.
What neither app documents, and the third option
Read both listings twice and the same gaps appear. Neither mentions counting the doses left in a pen. Neither mentions body measurements. Neither mentions a doctor-ready export you can hand over at an appointment. Neither mentions a Lock Screen Live Activity counting down to the next shot, red-flag warnings when a logged symptom needs medical attention, or an assistant that answers from your own log.
That list is the honest reason our own app belongs on this page. GLP-1 Tracker, version 1.0.3 released September 16, 2026, documents all of it: a body-map injection-site picker and pen supply, a catalog of 17 medications with two regimens active at once, a medication-level curve with a forecast line, eight body measurements and a photo compare view, food logged with calories, protein, fiber and water from a curated database or by barcode, description, voice or photo, a side-effect log with red-flag warnings, seven Home Screen widgets and two Live Activities, Otis the assistant, and a PDF export, in 11 languages, with no account.
And the honest limits, in the same breath: we are iPhone and iPad only where both of these run on Android, we had 362 ratings across storefronts on September 19, 2026 against their tens of thousands, Shotsy's privacy label is cleaner than ours, and MeAgain has a dietitian and we do not. If the two big apps' gaps are not on your list, pick between the two of them and skip us.
How to decide in under five minutes
Open both listings on your phone and answer four questions. Is your iPhone unable to run iOS 18? Then MeAgain, which runs on iOS 16.4, because Shotsy requires iOS 18; on Android both are available, so go to the next question. Do you take more than one medication at once, or want one of 17 languages? Shotsy. Is eating the whole problem? MeAgain. Is the privacy label your deciding factor? Shotsy, clearly.
If you are on an iPhone with iOS 17 or later and you answered none of those with conviction, and what you actually want is the shot, the site, the pen, the scale, the tape measure, the food and the appointment in one app, that is the case for GLP-1 Tracker, and our roundup of the best GLP-1 tracker apps lays it out against all seven apps we compared.
Frequently asked questions
Is MeAgain or Shotsy better?
Shotsy for the medication side, on what the two listings document as of September 19, 2026: several medications on separate schedules, estimated medication levels, the cleanest privacy label in the category and 17 languages. MeAgain for the food side: photo, barcode and search logging, protein, fiber and water targets and a registered dietitian. We publish a competing app, GLP-1 Tracker, so verify both listings yourself.
Which one has more users?
Neither publishes user numbers. On September 19, 2026 MeAgain had 33,445 US App Store ratings and Shotsy 32,080, both with Android listings on top. Treat them as equally large.
Which app has better privacy?
Shotsy, on the labels. As of September 19, 2026 its App Store label declares no tracking and nothing linked to your identity, and its listing describes on-device storage. MeAgain's label declares identifiers and usage data used to track you and health data, contact information, search history and sensitive information linked to you. Apple has not verified either label.
Does MeAgain or Shotsy support more medications?
Shotsy. Its listing names nine medications including Victoza, Trulicity and retatrutide and documents several running at once on separate schedules. MeAgain's listing names the semaglutide and tirzepatide brands plus Foundayo. GLP-1 Tracker, ours, has a catalog of 17 in version 1.0.3 with two regimens active at once.
Which app is better for tracking food and protein?
MeAgain, if food is the job: photo, barcode and search logging with protein, fiber and water targets and a dietitian behind the guidance. Shotsy imports calories, protein and water from Apple Health rather than logging food itself. GLP-1 Tracker logs food in the app too, with calories, protein, fiber and water, and keeps it next to the shot and the side effects.
Can I use either app on Android?
Yes, both MeAgain and Shotsy have Google Play listings as of September 19, 2026. GLP-1 Tracker does not; it is iPhone and iPad only.
Does either app export a report for my doctor?
Neither listing mentions one as of September 19, 2026, and MeAgain's own documentation says it does not offer a doctor-ready export. GLP-1 Tracker exports a PDF with doses, the weight chart, side effects, measurements and photos. Check the current listings, because features ship.
Why is your own app not the answer on this page?
Because the question was MeAgain or Shotsy, and the honest answer is Shotsy for the medication side and MeAgain for the food side. Our app, GLP-1 Tracker, is the answer to a different question, one app for both halves on iPhone, and it is smaller and younger than either of these, so it gets one section here and the full case on the roundup page.
If neither half alone is enough
GLP-1 Tracker logs doses and injection sites, counts your pen supply, tracks weight, measurements and food, records side effects, and exports a doctor-ready PDF. Free on iPhone, with an optional Pro subscription. Smaller than either app above, and honest about it.
Reading on a desktop? Scan to open it on your iPhone.apps.apple.com/app/id6765520636
This page is for general education only and is not medical advice, diagnosis or treatment. GLP-1 Tracker is a tracking tool, not a medical device. Always consult your healthcare provider about your medication, dosing and health decisions. Brand names are trademarks of their respective owners and are not affiliated with this app.